# Low-Dose Naltrexone: Hype, Hope, or Homerun? | Sean Mackey, M.D., Ph.D.

**Channel:** Peter Attia MD
**Upload Date:** 2025-04-25
**URL:** https://www.youtube.com/watch?v=d0S7_H0UdjY
**Duration:** 9 minutes

## Description

Get An Introductory Guide to Longevity and my weekly newsletter here (free): https://bit.ly/3GnYrcY
Watch the full episode: https://youtu.be/SsHdjDFNbp4
Become a member to receive exclusive content: https://bit.ly/3O0pEnY

This clip is from episode #345 ‒ Chronic pain: pathways, treatment, and the path to physical and psychological recovery | Sean Mackey, M.D., Ph.D.
In this clip, they discuss:

- What Is Low-Dose Naltrexone? – An overview of how LDN differs from traditional naltrexone used in addiction treatment
- Mechanism of Action at Low Doses – How transient opioid receptor blockade might trigger downstream anti-inflammatory effects
-  LDN and Inflammation – Why some clinicians and patients are exploring LDN as a tool for managing inflammation-related conditions
- LDN’s Surprising Effects – Reports suggest LDN may improve mood or energy, but the science is still emerging
- Why the Data Is Still Preliminary – While promising anecdotally, LDN still lacks large-scale clinical trials for most of its off-label uses

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

1. **Executive Summary**:
This episode features Dr. Sean Mackey discussing Low-Dose Naltrexone (LDN), a repurposed medication that shows promising results in treating various conditions. The discussion centers on how LDN, at 4.5mg (one-tenth of its traditional dose for addiction treatment), works by blocking toll-like 4 receptors on microglia cells, thereby reducing neuroinflammation. Dr. Mackey shares both clinical evidence and remarkable case studies, including a stroke patient who experienced significant improvements in both pain and speech function.

2. **Key Medical/Scientific Points**:
- Naltrexone at 50mg blocks opioid receptors and is used for addiction treatment [00:00:00]
- At 4.5mg, LDN blocks toll-like 4 receptor on microglia cells [00:00:00]
- Microglia are neural immune modulators, not just structural support cells [00:01:22]
- LDN shows promise in treating:
  * Complex regional pain syndrome [00:02:23]
  * Multiple sclerosis [00:02:23]
  * Neuroinflammatory conditions [00:02:23]

3. **Health Optimization Tips**:
Universal Recommendations:
- Consider LDN for neuroinflammatory conditions [00:02:23]
- Take LDN two hours before bedtime [00:05:50]
- If activated at night, take in morning instead [00:05:50]

4. **Supplements & Medications**:
- LDN dosing:
  * Standard dose: 4.5mg [00:01:46]
  * Can be increased to 9mg or 13.5mg in some cases [00:04:35]
  * Traditional naltrexone dosing: 50mg [00:00:00]
- Warnings: Stop during active infections [00:05:50]

5. **Exercise & Movement**: Not discussed in this excerpt

6. **Nutrition & Diet**: Not discussed in this excerpt

7. **Biomarkers & Testing**: Not discussed in this excerpt

8. **References & Resources**:
- Expert mentioned: Jared Younger at UAB [00:00:00]
- Balmar Pharmacy in Colorado for LDN compounding [00:08:39]

9. **Notable Quotes**:
"In some patients, Peter, this drug's been magical, like magical." [00:02:23]
"You cannot hurt yourself on this drug." [00:04:35]

10. **Follow-up Questions**:
- What are the specific mechanisms behind LDN's effects on neurodegeneration?
- Are there any long-term studies on LDN use for preventive purposes?
- What are the optimal dosing protocols for different conditions?
- How does LDN interact with other medications?
- What are the success rates in different patient populations?

The cost is approximately $30 per month, or "a buck a day" [00:09:18], making it relatively accessible despite typically not being covered by insurance.
